Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BEC . ammonium salt

Arginase inhibitor
 
ALX-270-345-M001 1 mg 44.00 USD
 
ALX-270-345-M005 5 mg 177.00 USD
Do you need bulk/larger quantities?
 
Slow-binding competitive inhibitor of arginase I (Ki=0.4-0.6µM & KD=2.22µM for recombinant rat liver arginase) and arginase II (Ki=0.31µM at pH 7.5 and 0.03µM at pH 9.5 for human recombinant type II arginase). Enhances NO-dependent smooth muscle relaxation in human penile corpus cavernosum tissue. Does not inhibit nitric oxide synthase (NOS) and may serve as a valuable reagent to probe the physiological relationship between arginase and NOS. Inhibitor of rat aortic smooth muscle cell proliferation.

Product Specification

Alternative Name:S-(2-Boronoethyl)-L-cysteine . NH4
 
Formula:C5H11BNO4S . NH4
 
MW:192.0 . 18.0
 
CAS:63107-40-4 (non-salt)
 
Purity:≥95% (TLC)
 
Appearance:White to off-white powder.
 
Solubility:Soluble in water (10mg/ml).
 
Shipping:Ambient
 
Long Term Storage:+4°C
 
Handling:Very hygroscopic. Keep under inert gas. Keep cool and dry.
 
ALX-270-345 structure
Please mouse over
ALX-270-345 structure

Product Literature References

Plasma arginine metabolites reflect airway dysfunction in a murine model of allergic airway inflammation: J. A. Scott, et al.; J. Appl. Physiol. (1985) 118, 1229 (2015), Application(s): Intratracheal Instillation , Abstract; Full Text
Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin: L.A. Holowatz, et al.; Am. J. Physiol. Heart Circ. Physiol. 291, H2965 (2006), Abstract;
Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism: J. Steppan, et al.; PNAS 103, 4759 (2006), Abstract; Full Text
Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium: A.S. Jung, et al.; Am. J. Physiol. Heart Circ. Physiol. 290, H1756 (2006), Abstract;
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response: L. Di Costanzo, et al.; PNAS 102, 13058 (2005), Abstract; Full Text
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels: D.E. Berkowitz, et al.; Circulation 108, 2000 (2003), Abstract; Full Text
Classical and slow-binding inhibitors of human type II arginase: D.M. Colleluori & D.E. Ash; Biochemistry 40, 9356 (2001), Abstract;
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation: L.H. Wei, et al.; PNAS 98, 9260 (2001), Abstract; Full Text
Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase: J.D. Cox, et al.; Biochemistry 40, 2689 (2001), Abstract;
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum: N.N. Kim, et al.; Biochemistry 40, 2678 (2001), Abstract;

Product Toolbox

PRODUCT RESOURCES

Print as PDF
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Arginase
By biological activity:
Arginase Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
Keep in touch

©2017 Enzo Life Sciences, Inc.,